<DOC>
	<DOCNO>NCT02251132</DOCNO>
	<brief_summary>The objective study establish tipranavir-ritonavir steady-state dose-exposure relationship administer b.i.d . dose regimen ; determine effect tipranavir ( TPV ) ritonavir ( RTV ) cytochrome P-450 ( CYP3A4 ) activity ; establish dependency TPV M1 metabolite RTV co-administration . Additionally , short-term safety tolerance drug combination evaluate .</brief_summary>
	<brief_title>Pharmacokinetics Tipranavir Soft Elastic Capsules ( SEDDS ) Ritonavir Their Effects Cytochrome P-450 ( 3A4 ) Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Tipranavir</mesh_term>
	<mesh_term>Erythromycin stearate</mesh_term>
	<mesh_term>Erythromycin</mesh_term>
	<mesh_term>Erythromycin Estolate</mesh_term>
	<mesh_term>Erythromycin Ethylsuccinate</mesh_term>
	<criteria>Male female 18 75 year age inclusive Female subject childbearing potential require use barrier contraceptive method least 3 month prior administration study medication , study medication administration 30 day end study Ability swallow numerous large capsule without difficulty A body mass index ( BMI ) 19 29 kg/m2 Signed informed consent prior trial participation Reasonable probability completion study Acceptable screen laboratory value indicate adequate baseline organ function require time screen . Laboratory value consider acceptable severity high Grade 1 base AIDS Clinical Trials Group ( ACTG ) Grading Scale . All laboratory value &gt; Grade 1 subject approval BIPI clinical monitor Acceptable medical history , physical examination , electrocardiogram , chest Xray require prior enter treatment phase study Willingness abstain alcohol 48 hour prior study Day 0 abstain alcohol duration study Willingness abstain ingest grapefruit grapefruit juice duration study Urine drug screen negative drug abuse Negative HIV serology Negative Hepatitis B surface antigen Hepatitis C antibody Female subject : positive serum pregnancy test Visits 1 2 OR breastfeed Receipt investigational medicine 30 day prior Day 0 Receipt know enzyme alter drug 30 day prior Day 0 , grapefruit grapefruit juice within 15 day prior Day 0 antibiotic within 10 day prior Day 0 Excessive cigarette smoking , define great 10 cigarette per day Blood plasma donation within 30 day prior Day 0 Subjects seat systolic blood pressure either &lt; 100 mg Hg &gt; 150 mm Hg ; rest heart rate either &lt; 50 beats/min &gt; 90 beats/min Subjects history illness allergy , opinion investigator , might confound result study pose additional risk administer tipranavir ritonavir subject Subjects acute illness within 2 week prior Day 0 Subjects currently take overthecounter drug within 7 day prior Day 0 , currently take prescription drug , opinion investigator consultation BIPI medical monitor pharmacokineticist , might interfere either absorption , distribution metabolism test substance Hypersensitivity tipranavir , ritonavir sulfonamide contain drug Evidence active substance abuse , investigator 's opinion , could affect study adherence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>